1 / 23

As early as 2010, in collaboration with Dr. Nobuto Yamamoto ,

A molecular model of the interaction between vitamin D binding protein-derived macrophage activating factor (GcMAF) and vitamin D receptor (VDR) -M1 shift. Maria Giulia Fiore, Stefano Magherini*, Gabriele Morucci, Jacopo Junio Valerio Branca, Stefania Pacini, Massimo Gulisano and Marco Ruggiero

moretz
Télécharger la présentation

As early as 2010, in collaboration with Dr. Nobuto Yamamoto ,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A molecular model of the interaction between vitamin D binding protein-derived macrophage activating factor (GcMAF) and vitamin D receptor (VDR) -M1 shift Maria Giulia Fiore, Stefano Magherini*, Gabriele Morucci, Jacopo Junio Valerio Branca, Stefania Pacini, Massimo Gulisano and Marco Ruggiero Department of Experimental and Clinical Biomedical Sciences, and Department of Experimental and Clinical Medicine, University of Firenze, 50134 Firenze, Italy

  2. As early as 2010, in collaboration with Dr. Nobuto Yamamoto, we demonstrated an interconnection between GcMAF and VDR signaling (XVIII International AIDS conference, Vienna 2010). We demonstrated that the responsiveness of human monocytes to GcMAF was associated with VDR gene polymorphisms.

  3. GcMAF • Is a member of the so-called vitamin D axis since it derives from de-glycosylation of Vitamin D-Binding Protein or Gc protein. • In 2010 and following years, we demonstrated that polymorphisms of the VDR gene, known to be associated with the highest responses to vitamin D receptor agonists, are associated also with the highest responses to GcMAF.

  4. This observation raises the question of whether there could be a molecular interaction between GcMAF and the VDR. • This question might appear odd at first, since for many years it had been thought that VDR was localized in the cytoplasm and in the nucleus, whereas GcMAF could not cross the plasma membrane and therefore had to be recognized by a surface receptor, possibly a lectin-type receptor. • (J. Biol. Chem, 1999, 274(16), 10697-10705)

  5. In support for the hypothesis of a GcMAF/VDR interaction, there is the observation that VDR translocates to the plasma membrane, and plasma-membrane associated VDR is responsible for the rapid, non-genomic, effects of vitamin D. • Thus, in order to verify the possibility of a molecular interaction between GcMAF and VDR, we compared the amino acid sequences corresponding to their respective vitamin D binding sites. • J. Cell. Biochem. 2002, 86(1), 128-135. • Calcif. Tissue Int. 2013, 92, 151-162.

  6. There are 23 hydrophobic amino acids near the amino terminus of GcMAF • (-----MKRVLVLLLAVAFGHALERGRDY) • and 23 amino acids near the carboxyl terminus of the VDR • (SFQPECSMKLTPLVLEVFGNEIS-----). • These are the sequences that bind vitamin D.

  7. If these two sequence are aligned (Fig. A), it is possible to observe not only that in both proteins there is a long stretch (13-14) of hydrophobic amino acids (highlighted in green in Fig. A, upper insert), but that 4 hydrophobic amino acids are identical (L L FG; indicated in yellow and in green above and under the alignment. The sequence of GcMAF is above). • 11 amino acids have similar functional valence (as indicated by the conventional symbols [*], [.] and [:].

  8. Nutrients. 2013 Jul 8;5(7):2577-89. doi: 10.3390/nu5072577

  9. A molecular interaction between the two proteins can therefore be proposed (Fig. A). • According to this model, the last 23 hydrophobic amino acids of VDR (VDR is on the right of Fig. A), located at the inner part of the plasma membrane (represented as a dotted line), could interact with the first 23 hydrophobic amino acids of the GcMAF (GcMAF is on the left of Fig. A) located at the external part of the plasma membrane, with vitamin D (represented in yellow) sandwiched in between the two vitamin D-binding proteins.

  10. Oleic acid, taken as an example of an unsaturated fatty acid bound to GcMAF, could stabilize the complex at the level of the plasma membrane. • In fact, both vitamin D and oleic acid are located in a shallow cleft of the GcMAF protein that makes them accessible to the plasma membrane. • Biochem. Biophys. Res. Commun. 1988, 153(3), 1019-1024.

  11. In addition to the mode of interaction proposed in Fig. A, there could be also another one that takes into consideration just this fact that Gc protein (and therefore also GcMAF) binds unsaturated fatty acids such as oleic acid. • The fatty acid binding site is located between domains II and III, that is between the positions 304 and 387.

  12. When we aligned the 23 hydrophobic amino acids of the VDR quoted above (represented in the insert in Fig. B; also in this case, the sequence of GcMAF is represented above that of VDR) and the corresponding hydrophobic amino acids of the unsaturated fatty acid binding site of GcMAF (in particular, those in position 356-386), we observed that there was a significant degree of functional homology. • In fact there are 8 amino acids with similar functional valence in a long stretch of hydrophobic amino acids (highlighted in blue).

  13. Therefore, it can be hypothesized that GcMAF and VDR have multiple sites of interaction at the level of the plasma membrane. • According to this model, the presence of vitamin D and oleic acid should facilitate the interaction between GcMAF and VDR. • This hypothesis is further strengthened by the observation that activated macrophages generate enough biologically active vitamin D so as to be detectable in the general circulation (Arch Biochem Biophys. 2012; 523: 95-102).

  14. However, the interaction between GcMAF and VDR could also occur inside the cell. • At variance with what previously thought, vitamin D does not cross freely the membrane, and the Gc protein/vitamin D complex is endocytised through a receptor-mediated mechanism. • Therefore, Gc protein (and hence GcMAF) can be found inside the cell.

  15. Once inside the cell, GcMAF could interact with VDR thanks to the presence of a string of acidic amino acids in the VDR sequence that bind the Gal-N-Ac moiety of GcMAF, but not to the non-deglycosylated (inactive) Gc protein. • In fact, inactive Gc protein with sialic acid bound to Thr 420 cannot bind the string of acidic amino acids in the VDR sequence.

  16. Gal-N-Ac

  17. The interaction between GcMAF and VDR explains the multiplicity of effects attributed to GcMAF, and the variety of clinical applications ranging from cancer to autism. • In fact, VDR is expressed in a great number of cell types and regulates a wide array of genes involved in the control of the major cell functions.

  18. The interaction between GcMAF and VDR also explains the M1 shift induced by GcMAF in macrophages. • In fact, activation of VDR modulates the expression of IL-1β, IL-6, TNF-α and TLRs that in turn are responsible for a shift toward the M1 phenotype. • Activation of these factors leads to a predominance of NF-κB and STAT1 that promotes M1 macrophage polarization. • J Clin Invest. 2012 Mar 1;122(3):787-95.

  19. Conclusions • GcMAF, just as many other agonists, might have multiple receptors mediating different biological effects. • Here, we demonstrate that a molecular interaction between GcMAF and VDR can be envisaged on the basis of sequence analyses. • This interactions helps explaining the multifaceted biological effects of GcMAF as well the induction of M1 shift.

More Related